A Study to Evaluate the Antibody Response of Influenza Vaccination Following Concomitant Exposure to Bimekizumab in Healthy Subjects

Clinical trial NCT03895385 · COMPLETED

Trial details

NCT number: NCT03895385
Sponsor: UCB Biopharma S.P.R.L.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2019-04-02
Primary completion: 2019-10-04
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.